These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32395138)

  • 1. Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy.
    Carrasco N; Chimeno J; Adrià-Mora M; Pérez-Calatayud MJ; Ibáñez B; Carmona V; Celada F; Gimeno J; Lliso F; Pérez-Calatayud J
    J Contemp Brachytherapy; 2020 Apr; 12(2):139-146. PubMed ID: 32395138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
    Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability.
    Fiorino C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Piazzolla A; Cozzarini C
    Radiother Oncol; 2002 Jun; 63(3):249-55. PubMed ID: 12142088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
    Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
    Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of inter- and intra-observer variabilities of catheter reconstruction on multi-catheter interstitial brachytherapy of breast cancer patients.
    Kallis K; Kaltsas T; Kreppner S; Lotter M; Strnad V; Fietkau R; Bert C
    Radiother Oncol; 2019 Jun; 135():25-32. PubMed ID: 31015167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
    Wang J; Zhang KS; Wang T; Liu Z; Wang RH; Zhang FQ; Yu L; Ran L; He JL; Wang YL; Wei LC; Shi M; Wang GQ; Wu CQ; Kang QJ; Yang J; Li S; Yang FY; Liu BG; Liu JY; Shi F; Su J; Yuan W; Drokow EK
    BMC Cancer; 2019 Dec; 19(1):1219. PubMed ID: 31842811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
    Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.
    Federico M; Hernandez-Socorro CR; Ribeiro I; Martin JG; Oramas MDR; Saez-Bravo ML; Jimenez PCL
    Radiat Oncol; 2019 Oct; 14(1):173. PubMed ID: 31585543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
    Glaser SM; Kim H; Beriwal S
    Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.